Democrats' "Better Deal" policy statement proposes significant changes for antitrust/competition enforcement* On July 24, 2017, Democratic Party leaders unveiled “A Better Deal,” their plan to improve economic conditions for the American working class. [1] A key element of the Better Deal plan to “lower the cost of living for families” involves a “crack down on monopolies and the concentration of economic power that has led to higher prices for consumers, workers, and small business.” [2] The plan includes proposals that could have significant effects on regulatory review of mergers as well as business practices in the pharmaceutical industry. More specifically, the proposals would raise the bar for obtaining merger approval from the Federal Trade Commission (“FTC”) and Department of
Share on
|
|
The US Democrats publish "A Better Deal" policy statement with proposals to change antitrust/competition enforcement
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
